The authors reply

Affiliations

¹ Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan.
² Clinical Trial Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan.
³ Department of Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan. Electronic address: yasuike@tokushima-u.ac.jp.

Free article

Comment

Hirofumi Hamano et al. Kidney Int. 2021 Apr.

Free article

. 2021 Apr;99(4):1026.

doi: 10.1016/j.kint.2021.01.009.

¹ Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan.
² Clinical Trial Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan.
³ Department of Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan. Electronic address: yasuike@tokushima-u.ac.jp.

No abstract available

Comment on

Diphenhydramine may be a preventive medicine against cisplatin-induced kidney toxicity.
Hamano H, Ikeda Y, Goda M, Fukushima K, Kishi S, Chuma M, Yamashita M, Niimura T, Takechi K, Imanishi M, Zamami Y, Horinouchi Y, Izawa-Ishizawa Y, Miyamoto L, Ishizawa K, Fujino H, Tamaki T, Aihara KI, Tsuchiya K. Hamano H, et al. Kidney Int. 2021 Apr;99(4):885-899. doi: 10.1016/j.kint.2020.10.041. Epub 2020 Dec 9. Kidney Int. 2021. PMID: 33307103
Diphenhydramine for the prevention of cisplatin-associated acute kidney injury.
Gupta S, Leaf DE. Gupta S, et al. Kidney Int. 2021 Apr;99(4):1025-1026. doi: 10.1016/j.kint.2021.01.007. Kidney Int. 2021. PMID: 33745534 No abstract available.